Updates in the Management of Hairy Cell Leukemia

home / peer-exchange / updates-in-the-management-of-hairy-cell-leukemia

EP. 1: Introduction and Epidemiology of Hairy Cell Leukemia

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 2: Molecular Genetic Changes for Hairy Cell Leukemia

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 3: Signs and Tests for Diagnosis and Prognosis of HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 4: Differential Diagnosis and Molecular Tests in Identifying HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 5: Determining When to Treat and First-Line Therapy for HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 6: Combination First-line Therapy in Hairy Cell Leukemia

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 7: When to Not Use Combination and the Need for Bone Marrow Biopsy in HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

$Historical Treatment for Relapsed/Refractory HCL$

EP. 8: Historical Treatment for Relapsed/Refractory HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

$Landscape Change in the Treatment of Relapsed/Refractory HCL$

EP. 9: Landscape Change in the Treatment of Relapsed/Refractory HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 10: The Role of CD22-targeted Immunotoxins in HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

$Treatments for Relapsed/Refractory HCL in Pipeline$

EP. 11: Treatments for Relapsed/Refractory HCL in Pipeline

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

EP. 12: Advice for Community Oncologists on Treating HCL

By Steven Coutre, MD, Stanford University Medical Center
Farhad Ravandi-Kashani, MD, MD Anderson Cancer Center

June 30th 2020

Latest Conference Coverage

Dr Deek on the Investigation of Immune Cell Infiltration in MIBC

Hypofractionated and Conventionally Fractionated Radiotherapy Generate Similar QOL, Safety in Breast Cancer

Dr Hoppe on the Rationale for the CheckMate 744 Trial in Hodgkin Lymphoma

Dr Chuong on the Patterns of Guided Radiation Therapy in Pancreatic Cancer

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512